Brickell Biotech, Inc. BBI
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 6.75M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.28
- Beta
- 0.08
- Short ratio
- 0.62
- Inst. own
- 13.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 11, 2022
- 50-d avg
- 3.10
- 200-d avg
- 8.30
- 1y target
- 17.83
MAX chart
Chart tools
Chart is warming up
The all-time price history for BBI has not been loaded yet. Try again in a moment.
Altman Z-Score
-7.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.5×
P/S 45.5×
P/B 0.7×
P/FCF -0.5×
EV/EBITDA 0.2×
EV/Sales -20.9×
FCF Yield -196.8%
Gross Margin 100.0%
Operating Margin -9753.7%
Net Margin -9787.9%
ROE -158.8%
ROIC -157.8%
ROA -133.1%
Revenue -77.8%
Operating Income -87.9%
EPS (diluted) 42.3%
Free Cash Flow -80.4%
Current Ratio 6.2×
Quick Ratio 6.2×
Debt / Equity 0.0×
Net Debt / EBITDA 0.7×
Interest Coverage -571×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2021-12-31